Cohance Lifesciences: Jasti Property Sells 1.33% Stake

Cohance Lifesciences Limited has received a revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Jasti Property and Equity Holdings Private Limited, acting as the sole Trustee of the Jasti Family Trust, sold 51,00,000 shares, representing 1.33% of the total share capital. This sale was conducted via inter-se transfer through block deals on November 9-11, 2026. Following the transaction, Jasti Property's holding decreased from 2.51% to 1.18% (total share capital) and from 2.37% to 1.11% (total diluted voting capital). The total holding of the acquirer and PACs before the transaction was 6.36% (total share capital) and 5.99% (total diluted voting capital), and after the transaction, it remains 6.36% (total share capital) and 5.99% (total diluted voting capital) due to an increase in the holding of Jasub Property Holdings LLP.